Sun Pharma's Strategic Leap: Acquiring Checkpoint Therapeutics | The Bengaluru Live

Sun Pharma’s Strategic Leap: Acquiring Checkpoint Therapeutics

Atul Chaturvedi 10 March 2025 1 minute read

📘 Read this story in Kannada

Sun Pharmaceutical Industries made headlines with their announcement of acquiring US-based Checkpoint Therapeutics, Inc for up to USD 355 million. Despite the initial market enthusiasm, the company’s shares eventually closed flat.

Atul Chaturvedi

Administrator

Atul Chaturvedi boasts over 25 years of experience in the media industry, having held positions at esteemed organizations such as Republic TV, Times Network's Mirror Now News Channel, Times of India, Bangalore Mirror, Rajasthan Patrika Hindi newspaper, and Sakal newspaper.

View All Posts

Atul Chaturvedi

President Accepts Dharmendra Pradhan’s Resignation; Pralhad Joshi Given Additional Charge of Education Ministry

Dharmendra Pradhan Resigns as Union Education Minister, Cites NEET-UG Controversy and Youth Interest

Minister Yathindra Siddaramaiah Reviews KUWSDB Projects, Orders Survey of All STP Units in Karnataka

Pejawar Seer Sri Vidyendra Tirtha to Observe 15th Chaturmasya Vrata in Bengaluru from August 8

Bengaluru Water Board Fines 692 Consumers for Misuse of Cauvery Drinking Water

Uttar Pradesh Youth Caught Allegedly Posing as Disabled Beggar in Bengaluru

Rahul Gandhi Demands Amit Shah’s Resignation Over Alleged Police Action Against Student Protesters

Rahul Gandhi Alleges RSS Influence Over Education System During Lok Sabha Debate

Leopard Spotted Again in Bengaluru’s Byadarahalli, Residents Raise Safety Concerns

You may have missed

Pejawar Seer Sri Vidyendra Tirtha to Observe 15th Chaturmasya Vrata in Bengaluru from August 8

Bengaluru Water Board Fines 692 Consumers for Misuse of Cauvery Drinking Water

Uttar Pradesh Youth Caught Allegedly Posing as Disabled Beggar in Bengaluru

Rahul Gandhi Demands Amit Shah’s Resignation Over Alleged Police Action Against Student Protesters

About us

Useful Links

Recent News

About the Author

Leave a Reply Cancel reply

Related Stories

You may have missed